Insulet Corporation provided revenue guidance for the quarter ending December 31, 2022. For the quarter ending December 31, 2022, the company expects revenue growth of 11% to 14%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
177.8 USD | -1.25% | -2.72% | -18.05% |
05-14 | Insulet Shares Rise Despite Blue Orca's Short Position | MT |
05-10 | Raymond James Adjusts Price Target on Insulet to $213 From $218 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.05% | 12.45B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.76% | 40.74B | |
+19.92% | 31.07B | |
+16.10% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Insulet Corporation Provides Revenue Guidance for the Quarter Ending December 31, 2022